-
-
-
-
-
-
News
-
-
Contact UsThe company focuses on the research, development, production, and sales of chemical raw materials and their formulations. All products have passed national GMP certification, and core products have successively passed official pharmaceutical regulatory certifications from multiple countries, including the EU EDQM, US FDA, Japanese PMDA, and South Korean MFDS. Following its successful listing on the Shenzhen Stock Exchange's ChiNext board on April 4, 2023, Keyuan Pharmaceutical has entered a phase of rapid development driven by both digital intelligence and capital, with its business spanning dozens of countries and regions worldwide.
Featured experimental platform
Continuous flow nitrification platform
Tianjin, Kale Ying
High-efficiency mass and heat transfer performance
Precise reaction parameter control
Intrinsic safety and ease of scale-up
Continuous flow hydrogenation platform
Tsinghua University, Jisong Zhang
Flexibility and multi-variety production
Easy to operate and maintain
Wide range of applications
Electrochemical platform
Tsinghua University, Kai Wang
Efficiency and Accuracy
Environmental Protection and Sustainability
Flexibility and Scalability
Chiral catalysis platform
Fudan University, Zhang Junliang
Highly efficient catalysis and selectivity
Mild and environmentally friendly reaction conditions
Wide range of applications
Enzyme catalysis platform
Chinese Academy of Sciences Zhang Yi Heng
Highly efficient and specific catalysis
Environmentally friendly and sustainable
Wide range of applications
Address: No. 26, Keyuan Street, Shanghe County, Jinan City, Shandong Province
Free Service Hotline